Product Images Doxorubicin Hydrochloride
View Photos of Packaging, Labels & Appearance
- Doxorubicin Hydrochloride - 1a930cb7 5363 4229 9f39 53edc07a43d6 01
- MPEG-DSPE - 1a930cb7 5363 4229 9f39 53edc07a43d6 02
- HSPC - 1a930cb7 5363 4229 9f39 53edc07a43d6 03
- pegylated liposome - 1a930cb7 5363 4229 9f39 53edc07a43d6 04
- Figure 1 - 1a930cb7 5363 4229 9f39 53edc07a43d6 05
- Doxo 20mg/10ml 10 ml vial label - 1a930cb7 5363 4229 9f39 53edc07a43d6 06
- Doxo 20mg/10ml 10 ml vial carton - 1a930cb7 5363 4229 9f39 53edc07a43d6 07
- Doxo 50mg/25ml 10 ml vial label - 1a930cb7 5363 4229 9f39 53edc07a43d6 08
- Doxo 50mg/25ml 10 ml vial carton - 1a930cb7 5363 4229 9f39 53edc07a43d6 09
Product Label Images
The following 9 images provide visual information about the product associated with Doxorubicin Hydrochloride NDC 68001-629 by Bluepoint Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Doxo 20mg/10ml 10 ml vial label - 1a930cb7 5363 4229 9f39 53edc07a43d6 06
This is information related to the storage and usage of Doxorubicin Hydrochloride Liposome Injection manufactured by BluePoint Laboratories. The medication should be refrigerated at 2° to 8°C (36° to 46° F) and should not be frozen. The recommended dosage, dilution process, and administration instructions are provided in the package insert. It is a cytotoxic medication in a liposomal formulation for intravenous infusion only after dilution. The text emphasizes not substituting the liposomal formulation with other versions of Doxorubicin Hydrochloride.*
Doxo 50mg/25ml 10 ml vial label - 1a930cb7 5363 4229 9f39 53edc07a43d6 08
This text is a set of storage instructions and dosage recommendations for Doxorubicin Hydrochloride Liposome Injection. It also includes details about dilution using 5% Dextrose Injection, USP. The package insert should be consulted for specific dosage information. A National Drug Code (NDC) number is provided along with indication for intravenous infusion after dilution. It is advised to discard any unused portion. The product is a liposomal formulation and not to be substituted for Doxorubicin Hydrochloride. The text also includes the manufacturer's information for the product.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.